Clinical Trial of Continuing Treatment for Patients Who Have Participated on a Prior Protocol Investigating Tanespimycin

Phase 2 Completed 6 enrolled Bristol-Myers Squibb

NaSingle-groupOpen-labelTreatment

Summary

The primary purpose of this study is to provide treatment to patients who have participated on a prior protocol investigating Tanespimycin (KOS-953,17-AAG)

Timeline

Start: 2006-07
Primary completion: 2013-03
Completion: 2013-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	tanespimycin	Unknown	—	Intravenous

Clinical Trial of Continuing Treatment for Patients Who Have Participated on a Prior Protocol Investigating Tanespimycin

Summary

Timeline

Drugs

Indications